[Interferons alpha-2a and gamma increase the antitumor activity, detected by histoculture drug response assay, of doxifluridine against clinical renal cell cancers].
Hirano
Y
Y
Dept. of Urology, Hamamatsu University School of Medicine.
Ushiyama
T
T
Suzuki
K
K
Fujita
K
K
D000970:Antineoplastic Agents / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D004357:Drug Synergism; D005467:Floxuridine / Q000494:pharmacology*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology*; D007680:Kidney Neoplasms / Q000473:pathology*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D005467:Floxuridine; D007371:Interferon-gamma; C025034:doxifluridine